0 Yorumlar
0 hisse senetleri
307 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
- Please log in to like, share and comment!
- All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Yorumlar 0 hisse senetleri 294 Views 0 önizleme
- Antibody Drug Conjugate Market Growth: Accelerating Precision Oncology to 2031The paradigm of cancer treatment is undergoing a radical shift, moving away from broad-spectrum therapies toward hyper-targeted solutions. Central to this movement is the Antibody Drug Conjugate Market Growth which is being fueled by a new generation of biopharmaceuticals that act as "biological missiles." These conjugates combine the immunological specificity of monoclonal antibodies with the...0 Yorumlar 0 hisse senetleri 226 Views 0 önizleme
- Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Yorumlar 0 hisse senetleri 184 Views 0 önizleme
- Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Yorumlar 0 hisse senetleri 159 Views 0 önizleme